Lilly sees decline in 2014 EPS, revenues

Eli Lilly and Co. (NYSE:LLY) introduced 2014 financial guidance on Tuesday that is in line with the Street's expectations but below the pharma's 2013 EPS and revenue guidance. The pharma said it expects 2014 revenue of $19.2-$19.8 billion and non-GAAP EPS of $2.77-$2.85. The Street is expecting 2014 EPS of $2.78 and revenue of $19.6 billion. The pharma reiterated its 2013 financial guidance of non-GAAP EPS of $4.10-$4.15 and revenue of $22.6-$23.4 billion. The Street is expecting EPS of $4.14 on revenues of $22.8 billion. Lilly is slated to report 4Q13 and 2013 earnings on Jan. 30. ...